Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
101.10
+1.81 (+1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
March 10, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
March 10, 2025
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?
Via
Investor's Business Daily
3 Growth Stocks to Stash
March 07, 2025
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...
Via
StockStory
Exposures
COVID-19
Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
March 02, 2025
Top mid-cap stock gainers in past week: Root, Bridge Investment Group, Huron Consulting, Medical Properties Trust, ZoomInfo Technologies, Lantheus Holdings, Alignment Healthcare, VSE. Analysts raise...
Via
Benzinga
Lantheus' Pylarify Hit $1B in 2024 Sales
February 27, 2025
Via
The Motley Fool
Earnings Scheduled For February 26, 2025
February 26, 2025
Via
Benzinga
Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals
February 25, 2025
Via
The Motley Fool
What 4 Analyst Ratings Have To Say About Lantheus Holdings
January 14, 2025
Via
Benzinga
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
February 26, 2025
Via
Benzinga
Lantheus (LNTH) Shares Skyrocket, What You Need To Know
February 26, 2025
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings...
Via
StockStory
Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars
February 26, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand,...
Via
StockStory
Why Lantheus Holdings (LNTH) Stock Is Down 4%
January 13, 2025
Lantheus shares are trading lower by 5.4% during Monday's session. The company announced a $350 million acquisition.
Via
Benzinga
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
January 06, 2025
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
February 25, 2025
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Via
StockStory
NASDAQ:LNTH is not too expensive for the growth it is showing.
February 21, 2025
LANTHEUS HOLDINGS INC was identified as a growth stock that isn't overvalued. NASDAQ:LNTH is excelling in various growth indicators while maintaining a solid financial footing.
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
February 21, 2025
Uncover the potential of LANTHEUS HOLDINGS INC, an undervalued stock. NASDAQ:LNTH maintains a strong financial position and offers an appealing valuation.
Via
Chartmill
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
January 31, 2025
LANTHEUS HOLDINGS INC was identified as an affordable growth stock. NASDAQ:LNTH is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably.
Via
Chartmill
NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying.
January 30, 2025
LANTHEUS HOLDINGS INC has a stellar value proposition. NASDAQ:LNTH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.
Via
Chartmill
Why Lantheus Holdings Stock Got Thrashed on Tuesday
January 29, 2025
Via
The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
January 03, 2025
Via
Benzinga
P/E Ratio Insights for Lantheus Holdings
December 18, 2024
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
January 28, 2025
Via
Benzinga
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
January 28, 2025
Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and Alzheimer's diagnostics.
Via
Benzinga
Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase.
January 28, 2025
Based on a technical and fundamental analysis of NASDAQ:LNTH we ask: Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Via
Benzinga
Topics
Government
Exposures
Political
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
January 10, 2025
Investors should take note ofLANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock that remains attractively priced.
Via
Chartmill
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
January 07, 2025
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
December 30, 2024
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying.
Via
Chartmill
2 Stock Market Predictions for 2025: 2 Stocks Worth Buying No Matter What Happens
December 30, 2024
Short-term market predictions are fun, but rarely worth investing in. Here are two stocks we think will be winners no matter what happens with the market in 2025.
Via
The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
December 20, 2024
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.